Norio Harada

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Gastric Inhibitory Polypeptide as an Endogenous Factor Promoting New Bone Formation after Food Ingestion

Katsushi Tsukiyama, Yuichiro Yamada, Chizumi Yamada et al. · Molecular Endocrinology · 2006 · 199 citations · Full text

Medicine, Endocrinology, Nutritional Sciences +17

Chronic Reduction of GIP Secretion Alleviates Obesity and Insulin Resistance Under High-Fat Diet Conditions

Daniela Nasteska, Norio Harada, Kazuyo Suzuki et al. · Diabetes · 2014 · 171 citations · Full text

Medicine, Endocrinology, Physiology +14

Free Fatty Acid Receptor GPR120 Is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion

Kanako Iwasaki, Norio Harada, Kazuki Sasaki et al. · Endocrinology · 2014 · 126 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice

Tatsuhito Himeno, Hideki Kamiya, Keiko Naruse et al. · Diabetes · 2011 · 111 citations · Full text

Medicine, Neuroscience, Pharmacology +17